Kintor Pharmaceutical Limited (HKG:9939)
Hong Kong
· Delayed Price · Currency is HKD 1.170
-0.040 (-3.31%)
Apr 25, 2025, 4:08 PM HKT
Kintor Pharmaceutical Market Cap
Kintor Pharmaceutical has a market cap or net worth of 506.57 million as of April 24, 2025. Its market cap has increased by 31.63% in one year.
Market Cap
506.57M
Enterprise Value
489.88M
Revenue
5.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.17
Market Cap Chart
Since May 22, 2020, Kintor Pharmaceutical's market cap has decreased from 7.94B to 506.57M, a decrease of -93.62%. That is a compound annual growth rate of -42.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 506.57M | 20.62% |
| Dec 31, 2024 | 419.98M | -42.42% |
| Dec 29, 2023 | 729.42M | -83.45% |
| Dec 30, 2022 | 4.41B | -7.54% |
| Dec 31, 2021 | 4.77B | 23.38% |
| Dec 31, 2020 | 3.86B | -51.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 211.76B |
| Hansoh Pharmaceutical Group Company | 140.64B |
| JD Health International | 115.75B |
| WuXi Biologics | 91.89B |
| Innovent Biologics | 84.80B |
| Akeso | 83.38B |
| Alibaba Health Information Technology | 75.59B |
| CSPC Pharmaceutical Group | 69.44B |